儿童间质性肺疾病分类、评估与管理更新:ATS临床实践指南
美国胸科学会(ATS)更新了2岁以下儿童间质性肺疾病(chILD)的临床实践指南,采用GRADE方法制定推荐。指南针对基因检测、胸部影像、肺活检和肺移植转诊提出推荐,包括对呼吸衰竭婴儿强烈推荐快速广泛基因检测,对特定chILD疾病强烈推荐肺移植评估转诊。
要点
- 呼吸衰竭的chILD婴儿强烈推荐快速广泛基因检测。
- 胸部CT仍是诊断评估的重要部分(条件推荐)。
- 特定chILD疾病预后差者强烈推荐转诊肺移植评估。
核心结论
- 该指南为2岁以下chILD患儿的基因检测、胸部影像、肺活检和肺移植转诊提供了循证推荐,以改善诊断评估和管理。
研究设计与样本
- 指南采用GRADES方法形成临床问题、总结证据并制定推荐,遵循ATS政策与流程,由多学科专家组制定。
主要发现
- 对呼吸衰竭的chILD婴儿推荐快速广泛基因检测(强推荐)。
- 胸部CT仍是诊断评估的重要部分(条件推荐)。
- 当需紧急明确特定chILD疾病且基因检测不可行、不及时或不确定时,或需识别组织病理学「可治疗特征」或判断预后时,推荐外科肺活检(强推荐)。
- 对预后可预测较差的特定chILD疾病患儿,推荐转诊肺移植评估(强推荐)。
- 对2岁前诊断的chILD患儿,建议重复胸部CT以辅助决策、判断预后和/或调整治疗(条件推荐)。
关键数值与推荐
- 快速广泛基因检测:强推荐用于呼吸衰竭的chILD婴儿。
- 胸部CT:条件推荐作为诊断评估的重要部分。
- 外科肺活检:强推荐用于需紧急明确特定chILD疾病且基因检测不可行、不及时或不确定时,或识别「可治疗特征」或判断预后时。
- 肺移植评估转诊:强推荐用于预后可预测较差的特定chILD疾病患儿。
- 重复胸部CT:条件推荐用于2岁前诊断的chILD患儿,以辅助决策、判断预后和/或调整治疗。
临床怎么用
- 临床应对呼吸衰竭的chILD婴儿及时进行快速广泛基因检测。
- 胸部CT应作为chILD诊断评估的重要组成,必要时可重复检查以指导治疗决策。
- 对特定chILD疾病且预后差者,应及时转诊进行肺移植评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Childhood interstitial lung diseases (chILD) are a heterogeneous group of rare disorders. In 2013, the American Thoracic Society (ATS) developed a guideline regarding the classification, evaluation, and management of children <2 years old with chILD. The current guideline provides updated recommendations regarding genetic testing, chest imaging, lung biopsy, and lung transplant referral. METHODS: The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to form clinical questions, summarize evidence, and develop recommendations, following ATS policies and procedures. A multidisciplinary panel with expertise in chILD formulated recommendations addressing diagnostic tools and referral for lung transplant evaluation. RESULTS: Rapid and broad genetic testing is recommended for infants with chILD and respiratory failure (strong recommendation). Chest computed tomography (CT) remains an important part of the diagnostic evaluation (conditional recommendation). Surgical lung biopsy is recommended when there is urgency to identify a specific chILD disorder and genetic testing is not feasible, timely, or inconclusive; to identify histopathologic "treatable traits"; or to inform prognosis (strong recommendation). Referral for lung transplant evaluation is recommended for children with specific chILD disorders with predictable poor outcomes (strong recommendation). Repeat chest CT to aid decision-making, prognosis, and/or change therapies is suggested for children with chILD diagnosed before age 2 years (conditional recommendation). CONCLUSIONS: This guideline provides evidence-based recommendations for genetic testing, chest imaging, lung biopsy, and referral for lung transplant evaluation to improve the diagnostic evaluation and management of children <2 years with chILD. Implementing this guideline will hopefully increase genetic testing for chILD, inform the diagnostic evaluation and disease monitoring of chILD, and identify future research priorities for chILD.
引用
- McGraw MD, DeBoer E, Weinman JP, et al. An update to the classification, evaluation, and management of childhood interstitial lung disease in infancy: an official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2026. PMID: 42496593. doi:10.1093/ajrccm/aamag375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。